2006
DOI: 10.1016/j.bmcl.2006.05.034
|View full text |Cite
|
Sign up to set email alerts
|

Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: Synthesis and biological evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 33 publications
(13 citation statements)
references
References 18 publications
0
12
0
Order By: Relevance
“…The latter acid 6 was treated with oxalyl chloride in the presence of a drop of DMF to provide the acid chloride 7 13, 14 . The acid chloride 7 was then coupled with KSCN to give the corresponding isothiocyanate derivatives 8 15, 16 .…”
Section: Resultsmentioning
confidence: 99%
“…The latter acid 6 was treated with oxalyl chloride in the presence of a drop of DMF to provide the acid chloride 7 13, 14 . The acid chloride 7 was then coupled with KSCN to give the corresponding isothiocyanate derivatives 8 15, 16 .…”
Section: Resultsmentioning
confidence: 99%
“…Before the generation of pharmacophore hypotheses, the training set compounds were converted into 3D structure to generate diverse conformations using the Diverse Conformation Generation protocol implemented in Discovery studio v3.5. Per molecule will generate the maximum numbers of 200 conformations to ensure maximum coverage of the conformational space by using Best conformation model generation method with CHARMm force field [32] and Poling algorithm [3336] module implemented in Discovery studio v3.5 was used to construct pharmacophore model in order to offer promising scaffolds for the development of novel and potent PTP-MEG2 inhibitors. The common feature pharmacophore generation used in this study was obtained by defining two properties-Pincipal and MaxOmitFeat of the ligands in the dataset that determined which molecules should be considered when building the pharmacophore space and which molecules should map to all or some of the features in the final pharmacophore.…”
Section: Methodsmentioning
confidence: 99%
“…In a previous communication 5 we described a series of compounds exemplified by 1 (Fig. 1) which combine potency at the 5-HT 2C receptor with good selectivity for this target and a favourable profile in vivo.…”
mentioning
confidence: 98%